Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C
Go back to Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C| RYDEX 2X S&P SELECT SECTOR FINANCIAL ETF (NYSE: RFL) | Delayed: 2.56 +0.09 (3.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.47 | 52 Week High | $17.54 | |||
| Open | $2.49 | 52 Week Low | $0.15 | |||
| Day High | $2.74 | P/E | N/A | |||
| Day Low | $2.49 | EPS | $0.00 | |||
| Volume | 138,587 | |||||
